Skip to content
Clinical Trials – home

Dermedic Jacek Zdybski

Verified siteinfo

Poland Henryka Sienkiewicza 65/14/II, 27-400 Ostrowiec Swietokrzyski, Poland

  • Alopecia areata · Dermatitis atopic · Neurodermatitis
  • Adults and children

About Specializations

Dermedic Jacek Zdybski in Ostrowiec Swietokrzyski, Poland specialises in clinical trials of conditions such as Alopecia areata, Dermatitis atopic, Neurodermatitis, Psoriasis, and other specialisations. This site conducts important research.

Main research areas of the site

Skin and Connective Tissue Diseases

The Dermatology department at Dermedic Jacek Zdybski conducts cutting‑edge studies in skin and connective tissue diseases, focusing on improving outcomes for patients with Plaque Psoriasis and Prurigo Nodularis. Current investigations aim to evaluate new therapeutic agents, assess patient‑reported itch relief, and ensure safety of topical treatments.

  • Dose‑response efficacy of rocatinlimab in prurigo nodularis
  • Safety and systemic exposure of IDP‑122 Lotion
  • Evaluation of HPA axis suppression potential after topical application
  • Pharmacokinetic profiling in pediatric plaque psoriasis

Located in Ostrowiec Świętokrzyski, Poland, the site contributes to European dermatology research with two active trials and a dedicated team of investigators.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Henryka Sienkiewicza 65/14/II27-400 Ostrowiec SwietokrzyskiPoland
Recruiting now
no trials
Conditions studied
5
Partner status
Verified site

More sites in Ostrowiec SwietokrzyskiPoland

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Vitiligo

Not recruiting

Study on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Pfizer Inc.

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Lunsekimig (SAR443765) for Adults with Moderate to Severe Atopic Dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Psoriasis

Not recruiting

Study on the Effects of IDP-122 Lotion for Children with Moderate to Severe Plaque Psoriasis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 65+ years
  • Substances:Halobetasol propionate
  • Sponsor:Bausch Health Americas Inc.

Alopecia areata

Not recruiting

Study on Rezpegaldesleukin for Treating Severe Alopecia Areata in Adults

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rezpegaldesleukin
  • Sponsor:Nektar Therapeutics

Neurodermatitis

Not recruiting

Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.